Select Publications
Book Chapters
, 2015, 'Prevention and Treatment of Infections in Patients with Autoimmune Blistering Disease', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 611 - 615, http://dx.doi.org/10.1007/978-3-662-45698-9_65
, 2015, 'Quality of Life in Autoimmune Blistering Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 623 - 631, http://dx.doi.org/10.1007/978-3-662-45698-9_67
, 2015, 'Rituximab and Its Use in Autoimmune Bullous Disorders', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 523 - 529, http://dx.doi.org/10.1007/978-3-662-45698-9_53
, 2015, 'Special Issues in Epidermolysis Bullosa: Eyes, Hair, Nails, Teeth and Pregnancy', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 695 - 709, http://dx.doi.org/10.1007/978-3-662-45698-9_73
, 2015, 'Supportive Care: Bathing, Wound Care, Nutrition, Pain and Itch Management, Psychosocial Support, Palliation', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 653 - 666, http://dx.doi.org/10.1007/978-3-662-45698-9_70
, 2015, 'Tetracyclines and Their Use in Autoimmune Bullous Diseases and Epidermolysis Bullosa', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 501 - 505, http://dx.doi.org/10.1007/978-3-662-45698-9_50
, 2015, 'The Pathogenesis, Assessment and Management of Pruritus in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 643 - 649, http://dx.doi.org/10.1007/978-3-662-45698-9_69
, 2015, 'The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 533 - 541, http://dx.doi.org/10.1007/978-3-662-45698-9_54
, 2015, 'Treatment and Prevention of Glucocorticoid-Induced Osteoporosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 593 - 603, http://dx.doi.org/10.1007/978-3-662-45698-9_63
, 2015, 'Treatment of Dermatitis Herpetiformis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 573 - 578, http://dx.doi.org/10.1007/978-3-662-45698-9_60
, 2015, 'Treatment of EB Complications: Esophageal Strictures, Pseudosyndactyly, Urethral and Meatal Stenosis, and Laryngeal Stenosis', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 687 - 694, http://dx.doi.org/10.1007/978-3-662-45698-9_72
, 2015, 'Using Intravenous Immunoglobulins in Autoimmune Bullous Diseases', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 515 - 521, http://dx.doi.org/10.1007/978-3-662-45698-9_52
, 2014, 'Pemphigus', in Evidence Based Dermatology Third Edition, pp. 552 - 560, http://dx.doi.org/10.1002/9781118357606.ch65
, 2011, 'Erythema Multiforme, Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis', in Harper S Textbook of Pediatric Dermatology Volume 1 Thrid Edition, pp. 78.1 - 78.8, http://dx.doi.org/10.1002/9781444345384.ch78
, 2011, 'Diagnosis and Prevention of Bullous Diseases', in Preventive Dermatology in Infectious Diseases, Springer London, pp. 53 - 73, http://dx.doi.org/10.1007/978-0-85729-847-8_6
, 2009, 'The Cochrane Skin Group', in Evidence Based Dermatology Second Edition, pp. 20 - 25, http://dx.doi.org/10.1002/9781444300161.ch4
, 2003, 'Interventions for bullous pemphigoid', in The Cochrane Library, John Wiley & Sons, UK
, 2003, 'Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita (Cochrane Review)', in Cochrane Database of Systematic Reviews, John Wiley & Sons Ltd, England
, 2003, 'The Cochrane Skin Group', in Williams H; Bigby M; Diepgen T; Herxheimer A; Naldi L; Rzany B (ed.), Evidence-based Dermatology, BMJ Publishing Group, London, UK, pp. 24 - 32
Journal articles
, 2026, 'Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey', British Journal of Dermatology, 194, pp. 165 - 167, http://dx.doi.org/10.1093/bjd/ljaf366
, 2026, 'Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases', International Journal of Dermatology, 65, pp. 18 - 27, http://dx.doi.org/10.1111/ijd.17964
, 2026, 'Response to Hassan and Paas, “Curbing paper mills in departments and journals”', Journal of the American Academy of Dermatology, 94, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2025.09.071
, 2026, 'Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study', British Journal of Dermatology, 194, pp. 163 - 165, http://dx.doi.org/10.1093/bjd/ljaf385
, 2025, 'P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases', British Journal of Dermatology, 193, http://dx.doi.org/10.1093/bjd/ljaf465.030
, 2025, 'Author Correction: Bullous pemphigoid (Nature Reviews Disease Primers, (2025), 11, 1, (12), 10.1038/s41572-025-00595-5)', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00605-6
, 2025, 'Bullous pemphigoid', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00595-5
, 2025, 'Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation', Australasian Journal of Dermatology, 66, pp. 468 - 474, http://dx.doi.org/10.1111/ajd.14592
, 2025, 'Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: Results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)', British Journal of Dermatology, 193, pp. 1101 - 1111, http://dx.doi.org/10.1093/bjd/ljaf236
, 2025, 'Enhancing randomized clinical trials with digital twins', Npj Systems Biology and Applications, 11, http://dx.doi.org/10.1038/s41540-025-00592-0
, 2025, 'Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials', Archives of Dermatological Research, 317, http://dx.doi.org/10.1007/s00403-025-04308-6
, 2025, 'Pilot Study of Tildrakizumab in the Treatment of Stable Non-Segmental Vitiligo', JEADV Clinical Practice, 4, pp. 1140 - 1145, http://dx.doi.org/10.1002/jvc2.70113
, 2025, 'Pioneers in Dermatology and Venereology: An interview with Professor Dedee F. Murrell', Journal of the European Academy of Dermatology and Venereology, 39, pp. 2032 - 2036, http://dx.doi.org/10.1111/jdv.70132
, 2025, 'Dual control of chronic plaque psoriasis and pouchitis with tildrakizumab', CLINICAL AND EXPERIMENTAL DERMATOLOGY, http://dx.doi.org/10.1093/ced/llaf468
, 2025, 'Erratum: Author Correction: Enhancing randomized clinical trials with digital twins (NPJ systems biology and applications (2025) 11 1 DOI: 10.1038/s41540-025-00592-0.)', Npj Systems Biology and Applications, 11, pp. 124, http://dx.doi.org/10.1038/s41540-025-00609-8
, 2025, 'Ofatumumab for the management of refractory pemphigus vulgaris: A case series', Jaad International, 22, pp. 94 - 96, http://dx.doi.org/10.1016/j.jdin.2025.05.018
, 2025, 'Evaluation of the responsiveness of the Keratosis Pilaris Investigator Global Assessment Score (KP-IGA) and composite KP Area Index (KPAI)', British Journal of Dermatology, 193, pp. 556 - 558, http://dx.doi.org/10.1093/bjd/ljaf163
, 2025, 'Linear Focal Elastosis: What We Know From Epidemiological Studies', Australasian Journal of Dermatology, 66, pp. 364 - 368, http://dx.doi.org/10.1111/ajd.14569
, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, 64, pp. 1546 - 1557, http://dx.doi.org/10.1111/ijd.17668
, 2025, 'Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel-S10', Journal of Dermatology, 52, pp. 1447 - 1451, http://dx.doi.org/10.1111/1346-8138.17884
, 2025, 'Space Oncology: A Comprehensive Scoping Review', Wilderness and Environmental Medicine, 36, pp. 148 - 171, http://dx.doi.org/10.1177/10806032251349442
, 2025, 'Dr. Dedee Murrell', The Nishinihon Journal of Dermatology, 87, pp. 369 - 370, http://dx.doi.org/10.2336/nishinihonhifu.87.369
, 2025, 'The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related Pruritus', Australasian Journal of Dermatology, 66, pp. 309 - 311, http://dx.doi.org/10.1111/ajd.14530
, 2025, 'Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres', Australasian Journal of Dermatology, 66, pp. 305 - 308, http://dx.doi.org/10.1111/ajd.14532
, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa', Clinical and Experimental Dermatology, 50, pp. 1238 - 1240, http://dx.doi.org/10.1093/ced/llaf016
, 2025, 'Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study', British Journal of Dermatology, 192, pp. 1007 - 1017, http://dx.doi.org/10.1093/bjd/ljaf022
, 2025, 'Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire', Journal of Health Psychology, 30, pp. 1476 - 1490, http://dx.doi.org/10.1177/13591053231221369
, 2025, 'Dermatologic manifestations of hereditary hemochromatosis: A systematic review', Journal of the European Academy of Dermatology and Venereology, 39, pp. 976 - 986, http://dx.doi.org/10.1111/jdv.20098
, 2025, 'Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires', Journal of Dermatology, 52, pp. 812 - 830, http://dx.doi.org/10.1111/1346-8138.17707
, 2025, 'Leveraging space innovations for cancer breakthroughs on Earth', Trends in Cancer, 11, pp. 433 - 440, http://dx.doi.org/10.1016/j.trecan.2025.02.003
, 2025, 'Linear IgA Bullous Dermatosis in Adults and Children: A Narrative Review of Literature on Disease Distribution and Evaluation of Existing Scoring Tools', Acta Dermatovenerologica Croatica ADC, 33, pp. 1 - 8